000			02007caa a22002778i 4500
001			585780028400
003			FR-PaOEC
005			20210419171534.0
006			a o d i
007			cr || |||m|n||
008			171201s2003 ||| o i|0| 0 eng d
035			_a(FR-PaOEC)
040			_aFR-PaOEC
100	1		_aBaygan, Günseli.
245	1	0	_aVenture Capital Policies in Israel _h[electronic resource] / _cGünseli Baygan = Politiques de capital-risque en Israël / Günseli Baygan
246	3	1	_aPolitiques de capital-risque en Israël
260			_aParis : _bOECD Publishing, _c2003.
300			_a18 p. ; _c21 x 29.7cm.
490	1		_aOECD Science, Technology and Industry Working Papers, _x18151965 ; _vno.2003/03
520	3		_aIsrael has a higher level of venture capital as a share of GDP than any OECD country. Most Israeli venture capital is channelled to early-stage companies, particularly start-ups in sectors based on information and communications technology (ICT) and biotechnology. The Israeli venture capital industry was built through government funding, particularly through the YOZMA group, which leveraged financing from foreign corporations and institutions. There is now a need for a change in tactics to maintain private venture funding for both portfolio and seed firms. While new incentives are being given to foreign investors, domestic venture investments could be encouraged through tax breaks, expanded opportunities for institutional investors, and reforms to the Israeli stock exchange. Israel needs to sustain growth in the venture sector while reducing dependence on a limited number of capital sources. This paper analyses trends in Israeli venture capital markets and makes policy ...
650		4	_aScience and Technology
651		4	_aIsrael _92867
830		0	_aOECD Science, Technology and Industry Working Papers, _x18151965 ; _vno.2003/03.
856	4	0	_aoecd-ilibrary.org _uhttps://s443-doi-org.br.lsproxy.net/10.1787/585780028400
942			_2ddc _cW-PAPER
999			_c365869 _d324431